期刊
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
卷 78, 期 5, 页码 1201-1210出版社
OXFORD UNIV PRESS
DOI: 10.1093/jac/dkad063
关键词
-
Resistance to antifolate drugs is prevalent in multidrug-resistant Staphylococcus aureus. Mutation in the drug targets and acquisition of genes encoding drug-insensitive proteins are the main mechanisms of resistance. A novel gene, dfrL, encoding a high-level resistant dihydrofolate reductase, was identified. This study provides important insights into the genotypes underlying staphylococcal resistance to antifolate drugs.
Objectives Antibacterial antifolate drugs might have a wider role in the management of staphylococcal infection. One factor that could potentially limit their use in this context is pre-existing resistance. Here we explored the prevalence and genetic basis for resistance to these drugs in a large collection (n = 1470) of multidrug-resistant (MDR) Staphylococcus aureus. Methods Strains were subjected to susceptibility testing to detect resistance to trimethoprim, sulfamethoxazole, co-trimoxazole and the investigational drug, iclaprim. Whole-genome sequences were interrogated to establish the genetic basis for resistance. Results According to CLSI breakpoints, 15.2% of the strains were resistant to trimethoprim, 5.2% to sulfamethoxazole and 4.1% to co-trimoxazole. Using the proposed breakpoint for iclaprim, 89% of the trimethoprim-resistant strains exhibited non-susceptibility to this agent. Sulfamethozaxole resistance was exclusively the result of mutation in the drug target (dihydropteroate synthase). Resistance to trimethoprim and iclaprim also resulted from mutation in the target (dihydrofolate reductase; DHFR) but was more commonly associated with horizontal acquisition of genes encoding drug-insensitive DHFR proteins. Among the latter, we identified a novel gene (dfrL) encoding a DHFR with similar to 35% identity to native and known resistant DHFRs, which was confirmed via molecular cloning to mediate high-level resistance. Conclusions This study provides a detailed picture of the genotypes underlying staphylococcal resistance to antifolate drugs in clinical use and in development. Prevalence estimates suggest that resistance to the diaminopyrimidines (trimethoprim/iclaprim) is not uncommon among MDR S. aureus, and considerably higher than observed for sulfamethoxazole or co-trimoxazole.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据